[PDF] Top 20 Las consecuencias jurídicas de no ser una provincia
Has 10000 "Las consecuencias jurídicas de no ser una provincia" found on our website. Below are the top 20 most common "Las consecuencias jurídicas de no ser una provincia".
Clinical utility of apixaban in the prevention and treatment of venous thromboembolism: current evidence
... the apixaban arm versus ...the apixaban arm and 4.3% for the enoxaparin arm (P = 0.03). The apixaban arm did not meet the prespecified criteria for noninferiority compared to the patients taking ... See full document
32
Cost effectiveness of apixaban versus low molecular weight heparin/vitamin k antagonist for the treatment of venous thromboembolism and the prevention of recurrences
... coagulant treatment at several treatment durations [14, ...with evidence from retrospective studies showing excess mortality in patients who develop VTE, even after adjusting for the increase as- ... See full document
5
Prevention of venous thromboembolism in hospitalized acutely ill medical patients: focus on the clinical utility of (low-dose) fondaparinux
... drugs, apixaban and rivaroxaban, cannot be currently recommended for VTE prevention in hospitalized medical ...VTE Prevention with Extended Duration Betrixaban Study) is presently evaluating the ... See full document
18
Safety of apixaban for venous thromboembolism prophylaxis: the evidence to date
... Abstract: Apixaban, a direct orally active anticoagulant (selective, direct factor Xa inhibitor) is approved for (primary) prevention of venous thromboembolism (VTE) in patients undergoing ... See full document
8
Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review
... of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism; AMPLIFY-EXT, Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein; CI, confidence interval; ... See full document
46
Profile of betrixaban and its potential in the prevention and treatment of venous thromboembolism
... Abstract: Venous thromboembolism (VTE), which includes deep vein thrombosis and pulmonary embolism, is a common and potentially preventable cause of morbidity and ...VTE prevention and ... See full document
13
New anticoagulants for the prevention of venous thromboembolism
... of apixaban for the prevention of throm- boembolism after major orthopedic surgery (ADVANCE ...the treatment period. In the ADVANCE 1 trial apixaban did not meet the criteria for ... See full document
14
Novel Oral Anticoagulants for Stroke Prophylaxis and Venous Thromboembolism Prevention and Treatment
... (Xarelto), apixaban (Eliquis) and edoxaban (Savaysa/ ...the current knowledge on these four anticoagulants will discuss their characteristics (Table 1), including mechanisms of action (Figure 1), ... See full document
12
Differentiation of parenteral anticoagulants in the prevention and treatment of venous thromboembolism
... the clinical and practical limitations of warfarin, new oral anticoagulants to replace warfarin have also been ...to evidence of its potential ...and apixaban – are currently in the final stages of ... See full document
42
Prevention of venous thromboembolism in patients undergoing bariatric surgery
... obesity treatment with established effectiveness. Venous thromboembolism (VTE) events, which include deep vein thrombosis and pulmonary embolism, are an important source of postoperative morbidity ... See full document
9
Update on the clinical use of the low-molecular-weight heparin, parnaparin
... in prevention of venous thromboembolism, in the treatment of chronic venous disorders, and in the treatment of venous and arterial (stable and unstable angina, acute ... See full document
17
Prevention and treatment of venous thromboembolism with low-molecular-weight heparins: Clinical implications of the recent European guidelines
... with current best practice, and facilitation of appropriate prescribing of prophylaxis ...[6,41]. Evidence suggests that the prevention of VTE can be improved by use of computerised reminders for ... See full document
16
New anticoagulants for the prevention and treatment of venous thromboembolism
... initial treatment of DVT, as effective as UFH for treatment of PE, and more effective than LMWH for prevention of VTE following orthopedic ...in clinical studies, with the rate of significant ... See full document
8
<p>Clinical utility of tafenoquine in the prevention of relapse of <em>Plasmodium vivax</em> malaria: a review on the mode of action and emerging trial data</p>
... with visual disturbances or impaired acuity/color vision. The keratopathy resolved within 1 year in all cases (incidence at 3 month 39% and at 6 month 10%). Fundoscopic assess- ments were made 3 months after the end of ... See full document
30
Elevated risk of venous thromboembolic events in patients with inflammatory myopathies
... VTE prevention by mechanical and pharmacological thromboprophylaxis in IMM patients, this method is still poorly implemented because of concerns about its safety in these ... See full document
48
Clinical utility of eslicarbazepine: current evidence
... adjunctive treatment in adult subjects with partial-onset seizures, with or without secondary generaliza- ...randomized clinical trials, and responder rates (percentage of patients with a $50% improvement ... See full document
6
Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence
... subsequent treatment after progression during the OVA-301 study was similar between the two arms (76% versus 77% for combination versus single agent arm); platinum-based regimens were less frequently administered ... See full document
16
Safety, efficacy, and clinical utility of macitentan in the treatment of pulmonary arterial hypertension
... the treatment of PAH, and has been shown in clinical trials to be well tolerated and clinically effective in both treatment- naïve patients and those on background ...tolerability, current ... See full document
9
Comparison of Apixaban and Low Molecular Weight Heparin in Preventing Deep Venous Thrombosis after Total Knee Arthroplasty in Older Adults
... Blood coagulation function indexes in two groups were com- pared. APTT, prothrombin time (PT), platelets (PLT), and fi- brinogen (FIB) were measured using a full-automated blood coagulation analyzer at 1 week after ... See full document
9
CASE REPORT: NEONATAL THROMBOSIS
... Like WISN, NPF is a medical emergency that requires rapid normalization of plasma protein C activity. Although fresh frozen plasma has been used as a source of exogenous protein C in the treatment of NPF, frequent ... See full document
30
Related subjects